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Lifestyle Intervention and Fatty Acid
Metabolism in Glucose-Intolerant Subjects
Marco Mensink, Ellen E. Blaak, Anton J. Wagenmakers, and Wim H. Saris
Abstract
MENSINK, MARCO, ELLEN E. BLAAK, ANTON J.
WAGENMAKERS, AND WIM H. SARIS. Lifestyle
intervention and fatty acid metabolism in glucose-intolerant
subjects. Obes Res. 2005;13:1354–1362.
Objective: Free fatty acid (FFA) oxidation is reduced in
subjects with type 2 diabetes mellitus and impaired glucose
tolerance (IGT). Weight reduction does not improve these
impairments. Because exercise training is known to increase
fatty acid (FA) oxidation, we investigated whether a com-
bined diet and physical activity intervention program can
improve FA oxidation in subjects with IGT.
Research Methods and Procedures: Sixteen subjects with
IGT were studied before and after 1 year of a lifestyle
intervention program [nine intervention (INT) subjects,
seven controls (CON)]. INT subjects received regular (i.e.,
every 3 months) dietary advice and were stimulated to
increase their level of physical activity. Glucose tolerance,
anthropometric characteristics, and substrate use at rest and
during exercise were evaluated before and after 1 year.
Substrate oxidation was measured at rest and during mod-
erate intensity exercise using indirect calorimetry in com-
bination with stable isotope infusion ([U-13C]palmitate and
[6,6-2H2-]glucose).
Results: After 1 year, no differences were seen in substrate
use at rest. During exercise, total fat and plasma FFA
oxidation were slightly increased in the INT group and
decreased in the CON group, with the change being signif-
icantly different (change after 1 year: INT, 2.0  1.4 and
1.9  0.9 mol/kg per minute; CON, 3.5  1.6 and
1.8  0.5 mol/kg per minute for total and plasma FFA,
respectively; p  0.05).
Discussion: A combined diet and physical activity interven-
tion program can prevent further deterioration of impaired
FA oxidation during exercise in subjects with IGT.
Key words: impaired glucose tolerance, fatty acid me-
tabolism, lifestyle intervention, stable isotopes, type 2
diabetes
Introduction
Disturbances in skeletal muscle fatty acid (FA)1 metab-
olism may play an important role in the development of
insulin resistance and type 2 diabetes (1,2). Several studies
have shown that the uptake and oxidation of free FA (FFA)
are impaired in insulin resistant (viscerally) obese subjects
(3) and type 2 diabetic subjects (4–6). An imbalance be-
tween uptake and oxidation of plasma FFA could lead to
accumulation of lipids within the muscle, which, in turn, is
strongly associated with insulin resistance (7,8).
It is difficult to assess the pathophysiological abnormal-
ities leading to type 2 diabetes when the type 2 diabetic state
has already developed because it is impossible to differen-
tiate between primary factors and adaptational responses.
Considerable weight reduction has not been shown to im-
prove the abnormalities in FA metabolism in type 2 diabetic
and obese subjects, suggesting that the abnormal FA me-
tabolism is primary rather than acquired (9). Recent findings
that impairments in FA uptake and oxidation are already
present in the prediabetic state of impaired glucose toler-
ance (IGT) (10,11) suggest that these disturbances could
play a role in the progression from IGT to type 2 diabetes.
It is well-known that endurance exercise training can alter
the capacity to oxidize FAs (12–14). Sial et al. (13) dem-
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onstrated that in elderly subjects, exercise training increased
total fat oxidation without a change in lipolysis or FFA
availability. Comparable data were found in obese and
healthy lean subjects using a low-intensity exercise program
for only a few hours weekly (12,14), a regimen much more
applicable for (obese) insulin-resistant subjects. Recently,
several well-controlled studies clearly showed that lifestyle
changes (i.e., changes in dietary and physical activity) sub-
stantially reduced the incidence of type 2 diabetes in high-
risk subjects (15–17). So far, little to no information is
available about the effect of such intervention programs on
the impaired FA metabolism found in IGT and type 2
diabetes. In the present study, a group of glucose-intolerant
subjects was studied before and after 1 year of a lifestyle
intervention program. Our aim was to investigate whether a
combined diet and physical activity intervention program
altered the capacity for (plasma-free) FA oxidation in sub-
jects with IGT, at rest as well as during exercise.
Research Methods and Procedures
The study on lifestyle intervention and IGT, Maastricht,
was designed to study whether a diet/physical activity in-
tervention program can improve glucose tolerance in sub-
jects with a high risk of developing type 2 diabetes. A
detailed description of the study can be found elsewhere
(18). In the present study, 16 subjects with IGT [nine
intervention (INT) subjects, seven controls (CON)] partici-
pating in the larger intervention trial underwent additional
measurements to evaluate the effect of this lifestyle inter-
vention program on substrate use and oxidation (for char-
acteristics, see Table 1). Subjects had no other reported
health problems and did not use any medication that could
interfere with substrate metabolism. The Medical Ethical
Review Committee of Maastricht University approved the
study protocol, and all subjects gave their written informed
consent before the start of the study.
Lifestyle Intervention
For a detailed description, see reference 18. Briefly, the
intervention program consisted of a dietary and a physical
activity component. Dietary recommendations were based
on the Dutch guidelines for a healthy diet (55 energy%
carbohydrates; 30 to 35 energy% fat intake, with 10
energy% intake of saturated FAs; a cholesterol intake of
33 mg/MJ; protein intake of 10 to 15 energy%; and an
intake of dietary fiber of at least 3 g/MJ). Dietary advice
was given by a skilled dietitian on an individual basis every
3 months. Subjects were stimulated to increase their phys-
ical activity to at least 30 minutes of moderate physical
activity a day for at least 5 d/wk. Individual advice was
given on how to increase their daily physical activity (walk-
ing, cycling, swimming). Furthermore, subjects were en-
couraged to participate in an exercise program consisting of
components of aerobic exercise training and components of
resistance training.
Subjects in the CON group were informed about the
beneficial effects of a healthy diet, weight loss, and in-
creased physical activity, but no individual advice or pro-
grams were provided. No additional appointments were
scheduled.
Methods
Before and after 1 year of the lifestyle intervention pro-
gram, several measurements were performed.
Glucose Tolerance Test. A standard oral glucose toler-
ance test (OGTT), with blood sampling at t 0, 30, 60, and
120 minutes, was performed to measure glucose tolerance.
Fasting plasma glucose (millimolar) and insulin concentra-
tion (milliunits per liter) were used to calculate an index for
insulin resistance with the homeostasis model assessment
(HOMA-IR) described by Matthews et al. (19).
Aerobic Capacity. An incremental exhaustive exercise
test was performed on an electronically braked bicycle
ergometer (Lode, Groningen, The Netherlands) to deter-
mine the maximal aerobic power output and oxygen con-
sumption (VO2max). The test started at a workload of 0.75
W/kg fat-free mass (FFM) for 3 minutes, followed by 3
minutes at 1.5 W/kg FFM. Thereafter, the workload was
increased every 3 minutes by 0.5 W/kg FFM until exhaus-
tion (respiratory quotient above 1.1 and no further increase
in oxygen uptake). During the experimental trials, subjects
exercised before and after 1 year at the same absolute
workload, i.e., 55% baseline VO2max.
Body Composition. Body weight (BW) was determined
on an electronic scale; body composition was determined by
hydrostatic weighing with simultaneous lung volume mea-
Table 1. Subject characteristics at baseline
Intervention Control
Number (men/women) 9 (5/4) 7 (5/2)
Age (years) 54.3 1.8 62.4 1.7*
Body weight (kg) 84.6 3.9 80.1 3.1
Body fat (%) 34.0 2.0 32.9 2.9
BMI (kg/m2) 29.3 0.6 27.9 1.2
Waist-to-hip ratio 0.97 0.02 0.97 0.03
VO2max (L/min) 2.22 0.17 2.22 0.15
Fasting glucose (mM) 6.1 0.5 5.7 0.2
2-Hour glucose (mM) 8.4 0.4 8.4 0.2
Fasting insulin (mU/L) 13.8 2.4 13.5 2.7
HOMA-IR index 3.9 1.0 3.4 0.6
Data are mean  SE.
* p  0.01 between groups.
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surement (Volugraph 2000; Mijnhardt, Bunnik, The Neth-
erlands), and calculated according to Siri (20). Waist and
hip circumference measurements were made to the nearest 1
cm with subjects standing in an upright position, one-half
way between the iliac spine and the last rib and at the level
of the trochanter major, respectively.
Substrate Use. Subjects participated before and after 1
year in two stable-isotope trials, separated by at least 1
week. Trials were performed in random order. Subjects
were asked not to participate in any (exhausting) physical
activity the last 3 days before the trials and not to consume
any products of high natural 13C-abundance during the last
week before both tests because this may disturb the 13C/12C
measurement in blood and expired air (21).
Experimental Trial. Subjects came to the laboratory at 8
AM after an overnight fast. Two cannulae were inserted, one
into an antecubital vein for the infusion of tracers and one in
retrograde direction into a contralateral dorsal hand vein for
blood sampling. The cannulated hand was placed in a hot
box to obtain arterialized venous blood. Background blood
and breath samples were taken 30 minutes after placement
of the cannulae. At t  0, an intravenous dose of 0.085
mg/kg BW NaH13CO3 was given to prime the bicarbonate
pool, followed by a constant rate continuous infusion of
[U-13C]palmitate (0.0067 mol/kg BW per minute). After
60 minutes, a continuous infusion of [6,6-2H2]glucose (0.3
mol/kg BW per minute) was started after a priming dose
had been given (18 mol/kg BW per minute). Tracers were
administered through a calibrated infusion pump (IVAC560
pump; IVAC, San Diego, CA). During the last 20 minutes
of the resting period (t 100, 110, and 120 minutes), breath
and blood samples were taken, and VO2 consumption and
VCO2 production were determined. Thereafter, exercise was
started for 1 hour (120 to 180 minutes). [U-13C]palmitate
infusion was doubled at the start of the exercise. During the
last 20 minutes, blood and breath samples were taken, and
VO2 consumption and VCO2 production were determined
(t  160, 170, and 180 minutes).
In a second trial, the acetate recovery factor (ARF),
necessary for correction of palmitate oxidation rates (22),
was determined as described before (11)
Tracers. The [U-13C]palmitate tracer (99% enriched;
Cambridge Isotope laboratories, Andover, MA) was dis-
solved in heated sterile water and passed through a 0.2-m
filter into 5% warm human serum albumin (Central Blood
Bank, Leiden, The Netherlands) to make a 0.65 mM solu-
tion. The [6,6-2H2]glucose and [1,2-13C]acetate tracer (99%
enriched, Cambridge Isotope Laboratories) were dissolved
in 0.9% saline to make an 18.7 and 3.0 mM solution,
respectively. The exact infusion rates of [U-13C]palmitate,
[6,6-2H2]glucose, and [1,2-13C]acetate were determined for
each experiment by measuring the concentration of the
infusate (see “Biochemical Methods”).
Breath, Blood, and Urine Sampling. Breath samples were
obtained by having the subjects breathe normally for at least
3 minutes into a mouthpiece connected to a 6.75-liter mix-
ing chamber. Breath samples were collected into a 20-mL
Vacutainer tube (Becton Dickinson, Meyland Cedex,
France) to determine the enrichment of CO2 (13C/12C ratio).
VO2 and VCO2 were determined by means of open-circuit
spirometry (Oxycon Beta; Mijnhardt). Arterialized blood
samples were collected in EDTA-containing tubes and were
immediately centrifuged at 3000 rpm at 4 °C; the plasma
was frozen in liquid nitrogen and stored at 80 °C until
analysis. Urine was collected overnight to determine nitro-
gen excretion for calculating the non-protein respiratory
exchange ratio.
Biochemical Methods. Breath samples were analyzed for
13C/12C ratio by injecting 20 L of the gaseous headspace
into a gas chromatograph (GC)-isotope ratio mass spec-
trometer (Finnigan MAT 252; Finnigan, Bremen, Ger-
many). Total plasma FFA, glucose, and infusate acetate
concentrations were measured using standard enzymatic
techniques (for FFA, FFA-C test kit, Wako Chemicals,
Neuss, Germany; for glucose, Roche Unikit III, Hoff-
man-La Roche, Basel, Switzerland; for acetate, kit no.
148261, Boehringer Mannheim, Mannheim, Germany). In-
sulin concentration during the experimental trial was mea-
sured using a double-antibody radioimmunoassay (Insulin
RIA-100; Kabi Pharmacia, Uppsala, Sweden); plasma insu-
lin levels during the OGTT were measured with an enzyme-
linked immunosorbent assay (Mercodia, Uppsala, Sweden).
For the determination of plasma palmitate concentration and
enrichment, FFAs were extracted from plasma, isolated by
thin-layer chromatography, and derivatized to their methyl
esters. Palmitate concentrations were determined on an an-
alytical GC with ion-flame detection using heptadecanoic
acid as an internal standard; on average, palmitate concen-
tration was 27  1% of total FFA concentration. Isotopic
enrichment of palmitate was determined by GC-isotope
ratio mass spectrometer after on-line combustion of FAs to
CO2 (Finnigan MAT 252), with correction for the extra
methyl group in the derivate. The concentration of infusate
palmitate was determined as described above for plasma
samples. For determination of glucose enrichment in
plasma, aliquots of EDTA plasma were extracted with
methanol:chloroform and chloroform:water. The clear wa-
ter layer was dried, and a butylboronic acid-acetyl derivate
was made. Subsequently, the enrichment of the glucose
derivate was determined by electron ionization/gas chroma-
tography mass spectrometry (Finnigan INCOS XL; Finni-
gan, San Jose, CA).
Calculations. Metabolic rate was calculated from VO2 and
VCO2 according to the equation of Weir (23). Carbohydrate
and fat oxidation rates were calculated from VO2 and VCO2
and urinary nitrogen excretion (24). Protein oxidation (as
calculated from nitrogen excretion) was assumed to be
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similar during the overnight fasted state and during exercise.
Total FA oxidation was calculated by converting the rate of
fat oxidation [triglyceride (TG) oxidation] to its molecular
equivalent, with the assumption of the average molecular
weight of TG to be 860 g/mol. Subsequently, the molar rate
of TG oxidation was multiplied by three to obtain FA
oxidation.
Enrichment of breath CO2 and plasma palmitate, acetate,
and glucose is given as the tracer-to-tracee ratio [TTR;
(13C/12C)sample  (13C/12C)background]. Fractional re-
covery of label in breath CO2, derived from the infusion of
labeled acetate, was calculated as follows: acetate recov-
ery (TTRCO2 VCO2)/2F, where F is the infusion rate of
acetate, and the number 2 in the denominator is to correct
for the number of 13C molecules in acetate.
Rate of appearance (Ra) and rate of disappearance (Rd)
were calculated according to Steele’s equation for steady
state (palmitate at rest) and Steele’s single-pool non-steady
state equations adapted for use with stable isotopes (palmi-
tate during exercise and glucose at rest and during exercise).
Volume of distribution was assumed to be 0.040 L/kg for
palmitate and 0.160 L/kg for glucose. Ra and Rd of FFA
were calculated by dividing palmitate Ra and Rd by the
fractional contribution of palmitate to the total FFA con-
centration. Percentage of infused [U-13C]palmitate oxidized
was calculated with the formula: percentage infused tracer
oxidized  ((TTR CO2  VCO2)/(16  F  acetate recov-
ery)) 100%, where F is the infusion rate of palmitate, and
the number 16 in the denominator is to correct for the
number of 13C molecules in palmitate. Plasma FFA oxida-
tion was calculated as: Rd FFA  percentage of infused
palmitate tracer oxidized, and TG-derived FA oxidation was
calculated as: total FA oxidation  plasma FFA oxidation.
During exercise, the Rd of glucose is identical to the mea-
sured oxidation rate (25); therefore, muscle glycogen oxi-
dation rates during exercise are calculated as: total glucose
oxidation  plasma glucose oxidation.
Statistical Analysis
Data are presented as means  SE. Oxidation rates and
Ra and Rd are expressed as micromoles per kilogram of
FFM per minute. Differences between groups were ana-
lyzed with a two-tailed Student’s t test for unpaired data,
and changes within groups were analyzed with a two-tailed
Student’s t test for paired data. Changes in concentration of
metabolites over time between groups were analyzed with a
two-way repeated-measures ANOVA. Statistical signifi-
cance was set at p  0.05.
Results
Subject Characteristics
No differences were found in baseline BW, BMI, body
composition, and maximal aerobic capacity between groups
(see Table 1). Subjects in the CON group were of older age
(INT, 54.3  1.8 years; CON, 62.4  1.7 years; p  0.01).
Baseline glucose tolerance and insulin resistance were com-
parable (see Table 1).
After 1 year, BW, body composition, aerobic capacity,
and insulin resistance showed a tendency to improve in the
INT group; however, differences between groups were not
statistically significant (Table 2). Waist-to-hip ratio de-
creased more in the INT group compared with the CON
group (INT,0.02 0.01; CON,0.02 0.01; p 0.05).
Relative workload at baseline and after 1 year of inter-
vention was comparable between groups (INT, before
51.5  2.1%, after 52.6  3.0% VO2max; CON, before
56.5 1.3%, after 57.4 3.0% VO2max). During the last 20
minutes of exercise, oxygen consumption had reached a
plateau.
Arterialized Concentrations of Metabolites
Table 3 depicts the concentration of circulating glucose,
FFA, and insulin at rest and during the last 20 minutes of
exercise before and after 1 year, for both groups. No dif-
ferences were observed between groups. FFA levels in-
creased and insulin levels decreased throughout the exercise
period to the same extent in both groups (ANOVA time
effect, p  0.05). Plasma palmitate, expressed as a fraction
of total FFA, was not different between groups either before
or after 1 year (mean 27  1% of total FFA).
Tracer Kinetics
Plasma glucose TTR at rest and during exercise and
plasma palmitate TTR during exercise slightly decreased
over time (data not shown); therefore, Steele’s non-steady
state equations were used to calculate substrate kinetics. No
differences were observed between groups in plasma palmi-
Table 2. Change in subject characteristics
Intervention
(n  9)
Control
(n  7)
Body weight (kg) 0.8 1.1 1.0 0.9
Body fat (%) 0.3 0.9 0.2 1.0
BMI (kg/m2) 0.3 0.4 0.3 0.4
Waist-to-hip ratio 0.02 0.01 0.02 0.01*
VO2max (L/min) 0.03 0.06 0.03 0.07
Fasting glucose (mM) 0.1 0.1 0.1 0.1
2-Hour glucose (mM) 0.3 0.4 0.5 0.8
Fasting insulin (mU/L) 0.4 1.5 2.9 2.4
HOMA-IR index 0.1 0.5 0.8 0.6
Data are mean  SE.
* p  0.01 between groups.
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tate and glucose TTR. Furthermore, no differences were
found between baseline and year 1 in plasma palmitate and
glucose TTR (data not shown). No significant differences in
ARF were observed between groups at rest (before, 23.8 
1.0% vs. 21.8  1.2%; after, 22.9  1.0% vs. 21.3  0.9%
for INT and CON, respectively) or during exercise (before,
60.7  3.3% vs. 61.0  1.9%; after, 59.4  3.9% vs.
68.3  2.4% for INT and CON, respectively).
Energy Expenditure and Substrate Oxidation
Energy expenditure was comparable between groups and
did not significantly differ before and after 1 year, at rest
and during moderate intensity exercise (data not shown). Ra
and Rd of glucose and FAs were comparable between
groups, before and after 1 year of the lifestyle intervention
program (see Table 4).
Oxidation rates are given in Table 5 (expressed as mi-
cromoles per kilogram of FFM per minute) and Figure 1
(expressed as relative contribution to energy expenditure
during exercise). Total FA oxidation during exercise was
slightly elevated in the CON group at baseline (p  0.05).
However, when corrected for total energy expenditure, no
differences were observed between groups in substrate ox-
idation at baseline (Figure 1). After 1 year of intervention,
resting carbohydrate oxidation was lower in the INT group,
without a significant change in FA oxidation. During exer-
cise, total carbohydrate and glycogen oxidation were in-
creased in the CON group, whereas these variables slightly
decreased in the INT group, with the change after 1 year
being significantly different between groups (p  0.05;
Table 4 and Figure 1). Total FA and plasma FFA oxidation
during exercise were increased in the INT group and de-
creased in the CON group (p for difference in change 
0.05). After 1 year, subjects in the INT group tended to rely
more on FA oxidation during exercise compared with CON
(INT, 53.0  4.2% vs. CON, 43.1  1.8% of total energy
expenditure; p  0.07; see Figure 1).
Discussion
Several studies have shown that the uptake and oxidation
of FFA are impaired in type 2 diabetic patients (4,5) and in
Table 3. Circulating metabolites
Rest
Exercise ANOVA
160 170 180 Group Time Inter.
Glucose (mM)
Before
INT 5.6 0.3 5.4 0.2 5.4 0.2 5.3 0.2 — — —
CON 5.3 0.1 5.4  0.2 5.4 0.2 5.4  0.2 — — —
After
INT 5.8 0.5 5.6  0.3 5.5 0.3 5.5  0.3 — — —
CON 5.5 0.1 5.4  0.1 5.4 0.2 5.5  0.2 — — —
FFA (M)
Before
INT 718 105 733 103 818 110 874 121
CON 641 69 742  84 856 90 859  72 — 0.01 —
After
INT 708 80 736  96 813 98 852  95
CON 681 93 700  70 806 85 885  99 — 0.01 —
Insulin (mU/L)
Before
INT 9.4 2.0 8.2  1.2 8.2  1.4 6.5  0.6
CON 9.5 1.2 7.0  0.8 6.8 0.9 6.7  0.8 — 0.05 —
After
INT 11.2 2.1 9.2 1.4 8.8  0.4 9.0  1.2
CON 11.7 1.4 9.5 1.0 9.6 0.9 8.5  0.9 — 0.01 —
Date are mean  SE. inter., group  time interaction.
160, 170, and 180 are mintues into the trial and represent the last 20 minutes of the 60-minute exercise period of the trial.
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the prediabetic condition of IGT (11). In the present study,
subjects with IGT were restudied after 1 year of a lifestyle
intervention program. The most important finding was that
subjects in the INT group maintained their capacity to
oxidize (plasma free) FAs, whereas in the CON group,
(plasma free) FA oxidation was decreased. Thus, a com-
bined diet and physical activity intervention program may
be able to prevent a further impairment in FA use in subjects
with IGT.
Methodological Considerations
FA kinetics were determined with use of the stable iso-
tope [U-13C]palmitate in combination with indirect calorim-
etry. To correct for the loss of 13C label due to fixation in
products of the tricarboxylic acid cycle and the bicarbonate
pool, Sidossis introduced the ARF (26). Failure to use the
ARF may lead to a substantial underestimation of plasma
FFA oxidation. The ARF needs to be determined in every
subject under the same circumstances and at the same
Table 4. Substrate kinetics for intervention (n  9) and control (n  7) groups
Baseline 1 Year
Intervention Control Intervention Control
Rest
Plasma Glucose Ra 16.5 1.5 17.5 0.7 15.8 1.5 16.6 1.3
Plasma Glucose Rd 17.4 1.3 17.7 0.5 17.2 1.7 17.1 1.3
Plasma FFA flux 14.6 2.1 12.1 1.3 15.7 1.8 12.2 1.4
Exercise
Plasma glucose Ra 27.4 1.6 29.5 2.9 26.0 2.3 29.3 2.7
Plasma glucose Rd 27.7 1.8 29.3 3.0 26.7 2.5 28.4 2.9
Plasma FFA Ra 22.5 2.6 21.5 1.8 24.3 2.3 21.8 1.5
Plasma FFA Rd 22.5 2.6 21.5 1.8 24.3 2.3 21.8 1.5
Data are mean  SE and are expressed as micromoles per kilogram of FFM per minute.
Table 5. Fuel oxidation rates for intervention (n  9) and control (n  7) groups
Baseline 1 Year Change
Intervention Control Intervention Control Intervention Control
Rest
Carbohydrate 10.4 1.1 11.9 0.8 8.2 1.1 11.4 0.8† 2.2 1.4 0.5 1.2
Total FA 3.8 0.5 3.2 0.1 3.7 0.3 3.1 0.3 0.2 0.6 0.1 0.4
Plasma FFA 5.5 0.8 4.4 0.4 5.5 0.5 4.7 0.8 0.0 0.6 0.3 0.7
TG-derived FA 1.6 0.5 1.2 0.5 1.8 0.5 1.7 0.7 0.2 0.5 0.4 0.6
Exercise
Carbohydrate 71.5 8.0 74.8 9.2 67.7 9.5 90.4 6.5* 3.9 5.7 15.6 4.5†
Plasma glucose 27.7 1.8 29.3 3.0 26.7 2.5 28.4 2.9 0.9 1.4 0.8 2.0
Glycogen 43.9 6.7 45.5 8.2 40.9 8.1 62.0 7.1* 2.2 5.6 16.5 3.4†
Total FA 16.7 1.6 21.5 1.2 18.7 1.2 18.0 1.3 2.0 1.4 3.5 1.6†
Plasma FFA 15.7 1.7 17.9 1.7 17.6 1.5 16.0 1.7* 1.9 0.9 1.8 0.5‡
TG-derived FA 1.0 1.5 3.6 1.3 1.2 1.6 2.0 1.6 0.1 1.8 1.6 1.2
Data are mean  SE and are expressed as micromoles per kilogram of FFM per minute.
* p  0.05 for difference between baseline and 1 year within groups.
† p  0.05 for difference between groups.
‡ p  0.01 for difference between groups.
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time-points as the palmitate infusion test because of a large
inter-individual variation in the ARF, especially during ex-
ercise (22).
Part of the (labeled) palmitate taken up by muscle at rest
can be incorporated into intramyocelluar TGs. These la-
beled FAs can be oxidized during exercise and appear as
13CO2 in breath. Although intramyocelluar TG is used as an
energy substrate during exercise, its relative contribution is
not completely clear. Thus, a small proportion of the 13CO2
appearing in breath during exercise can be due to TG-
derived FA oxidation and not plasma FFA oxidation. This
overestimation of plasma FFA oxidation made during ex-
ercise introduces only a small error, which has little impact
on the interpretation of our results.
The FFA kinetic data presented in this manuscript are
quite comparable with results obtained, and published, in
earlier studies in our laboratory, with comparable protocols
and patients (11,14,27). However, compared with findings
in other studies, FFA flux at rest is relatively high (28–30).
Several factors can underlie this difference, i.e., metabolic
status (glucose-intolerant vs. normoglycemic subjects), pe-
riod of measurement, protocol (stable isotopes vs. radioac-
tive isotopes; arterialized venous blood sampling vs. arterial
sampling), and subject characteristics (sex; aerobic capac-
ity). In the present study, substrate kinetics were measured
before and after intervention in experimental and CON
groups. Conclusions are based on observed changes within
groups and between groups.
Lifestyle Intervention
The intervention strategy we used in this study was based
on general public health recommendations for dietary intake
and physical activity (18). Such a regimen is much more
suitable for preventing diabetes because it is less time
consuming and much better tolerated than very intensive
tightly controlled intervention programs. Dietary intake was
monitored with a 3-day food record. However, this method
does not give valid results for small groups (as was the case
in this study). In the larger group from which the subjects
were selected, evaluation of the nutrient intake data clearly
showed beneficial changes: a decrease in total and saturated
fat intake and an increase in fiber intake [see Mensink et al.
(17)].
As a consequence of our intervention strategy, changes in
subject characteristics were less profound as compared with
more intense diet and exercise programs. Changes in body
composition and glucose homeostasis after 1 year of inter-
vention found in the present study, however, reflected the
results seen after 1 year in the larger intervention trial [INT
group (n 47), BW,2.7 0.5 kg; VO2max,0.10 0.03
L/min; 2-hour glucose, 0.8  0.3 mM; CON group (n 
55), BW 0.2  0.5 kg; VO2max, 0.0  0.03 L/min;
2-hour glucose, 0.2  0.3 mM; p  0.05 for difference in
change; see Mensink et al. (17)], indicating that to detect
statistically significant differences in such parameters as
glucose tolerance (measured by an OGTT) and body com-
position, larger groups are required. Nevertheless, for the
purpose of this study, substrate use and oxidation measured
by stable isotopes, group size is sufficient.
Substrate Oxidation
The main novel finding of the present study was that,
after 1 year of a lifestyle intervention program, subjects in
the INT group maintained their capacity to oxidize (plasma-
free) FAs during exercise, whereas in the CON group,
(plasma-free) FA oxidation was decreased. Due to the
slightly higher total FA oxidation in the CON vs. INT
groups at baseline (Table 5), it cannot be excluded that some
regression to the mean underlies the observed changes.
However, the altered fat oxidative capacity is supported by
the observation in a comparable group of subjects on the
same intervention program that lifestyle changes resulted in
changes in expression of genes and proteins, reflecting a
better capacity to oxidize FAs (26). In that study, a down-
regulation of acetyl CoA-carboxylase (ACC)-2 and an in-
crease in 3-hydroxyacyl-CoA dehydrogenase (HAD) pro-
tein content in skeletal muscle were observed in the INT
group, compared with an increase of ACC2 and no change
in HAD in the CON group (31).
It has been shown that substantial weight loss does not
improve the impaired capacity to use plasma FFA in type 2
diabetic subjects (9). Our data indicate that a combined
program of aerobic exercise, changes in diet composition,
Figure 1: Fuel oxidation during exercise for INT (n 9) and CON
(n  7) groups. Data are expressed as relative contribution to total
energy expenditure (Energy%). Change over time is depicted
between parentheses. * p 0.05 for difference in change over time
between groups.
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and weight loss may be able to compensate for the impaired
oxidation of (plasma-free) FAs, compared with the lack of
improvement found after weight loss per se. It is possible
that the positive effects on fat metabolism can be ascribed to
the inclusion of physical activity in the program. Indeed, it
has been shown that aerobic exercise training can increase
fat oxidation in different populations (12–14). A 16-week
training program increased fat oxidation during exercise in
elderly subjects (mean age 74 years), which was likely
related to alterations in skeletal muscle FA metabolism (13).
Comparable data were found in healthy lean (12) and obese
(14) men after low-intensity training sessions for only a few
hours weekly, a regimen more comparable with the present
intervention program. The observed maintenance or even
slight improvement of the capacity to oxidize (plasma-free)
FAs in the INT group suggests that the positive effects of
exercise can also be translated to the prediabetic condition
of IGT. Secondly, besides weight reduction, the diet inter-
vention program was directed toward a reduction of the
amount of fat, particularly saturated fat, in the diet. Changes
in dietary composition can also have an effect on substrate
use and oxidation. For example, a change in the dietary
polyunsaturated-to-saturated fat ratio can modulate the ox-
idation of fat and carbohydrate not only acutely after a meal
but also after chronic feeding (32).
Thus, the present study shows, for the first time, to our
knowledge, that the combination of an increased level of
physical activity, weight loss, and a change in dietary intake
can slow down the worsening of disturbances in FA metab-
olism in the prediabetic condition of IGT. This could be
important in relation to the development of insulin resis-
tance and the progression from IGT to type 2 diabetes.
Underlying Mechanisms
Several mechanisms could be responsible for the dimin-
ished capacity of the (pre)diabetic muscle to oxidize FAs.
An increased concentration of malonyl-CoA, possibly due
to dysregulation by ACC and malonyl CoA decarboxylase
or hyperglycemia, leading to inhibition of carnitine-palmi-
toyl transferase-1, has been suggested to explain the dimin-
ished ability to oxidize FAs (2,33). As stated earlier, we
observed that in a comparable group of subjects, lifestyle
changes resulted in a down-regulation of ACC-2 in skeletal
muscle (31). In line with this, Schrauwen et al. (12) showed
that a minimal amount of physical activity significantly
decreased ACC-2 mRNA expression in human skeletal
muscle and increased fat oxidation. Furthermore, endurance
training increases skeletal muscle capillarization and mito-
chondrial density (34) and increases the activity of several
enzymes involved in FA transport, transfer of FAs into
mitochondria (carnitine-palmitoyl transferase), and -oxi-
dation (HAD) (35,36). Muscle biopsy data indicate that the
insulin-resistant skeletal muscle is characterized by a dimin-
ished content of oxidative enzymes (5,37). Thus, an increase
in (mitochondrial) enzyme activity could underlie the dif-
ferences in FA oxidation between groups found in this study
after 1 year of intervention.
In conclusion, after 1 year of a combined diet and phys-
ical activity intervention program, the INT group showed a
maintenance of the capacity to oxidize (plasma-free) FAs
during exercise as compared with a reduced capacity in the
CON group. This indicates that a lifestyle intervention pro-
gram can prevent a further deterioration of disturbances in
FA metabolism found in subjects with IGT.
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